These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12969164)

  • 1. Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan.
    Usami T; Nakao N; Fukuda M; Takeuchi O; Kamiya Y; Yoshida A; Kimura G
    Kidney Int; 2003 Oct; 64(4):1445-9. PubMed ID: 12969164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.
    Furumatsu Y; Nagasawa Y; Hamano T; Iwatani H; Iio K; Shoji T; Ito T; Tsubakihara Y; Imai E
    Nephrol Dial Transplant; 2008 Mar; 23(3):984-90. PubMed ID: 17956890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences in end-stage renal disease and amount of protein intake in Japan.
    Motokawa M; Fukuda M; Muramatsu W; Sengo K; Kato N; Usami T; Yoshida A; Kimura G
    J Ren Nutr; 2007 Mar; 17(2):118-25. PubMed ID: 17321951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease.
    Usami T; Kimura G
    Clin Exp Nephrol; 2006 Mar; 10(1):8-12. PubMed ID: 16544172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different regional dynamics of end-stage renal disease in Japan by different causes.
    Kato N; Usami T; Fukuda M; Motokawa M; Kamiya Y; Yoshida A; Kimura G
    Nephrology (Carlton); 2005 Aug; 10(4):400-4. PubMed ID: 16109089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional variations in the incidence of end-stage renal failure in Japan.
    Usami T; Koyama K; Takeuchi O; Morozumi K; Kimura G
    JAMA; 2000 Nov 22-29; 284(20):2622-4. PubMed ID: 11086370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low birth weight and end-stage renal disease: demographic analysis by region in Japan.
    Ichikawa T; Fukuda M; Wakamatsu-Yamanaka T; Sato R; Naito T; Togawa H; Sasakawa Y; Tomonari T; Mizuno M; Miura T; Kato Y; Ono M; Shirasawa Y; Ito A; Yoshida A; Kimura G
    Clin Exp Nephrol; 2012 Aug; 16(4):596-603. PubMed ID: 22302087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE-inhibitor use and the long-term risk of renal failure in diabetes.
    Suissa S; Hutchinson T; Brophy JM; Kezouh A
    Kidney Int; 2006 Mar; 69(5):913-9. PubMed ID: 16518351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ACE inhibitors and calcium antagonists on progression of chronic renal disease.
    Epstein M
    Blood Press Suppl; 1995; 2():108-12. PubMed ID: 7582066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors.
    Savage S; Schrier RW
    Adv Intern Med; 1992; 37():85-101. PubMed ID: 1558007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic differences in the increasing ESRD rate have disappeared in Japan.
    Wakamatsu-Yamanaka T; Fukuda M; Sato R; Naito T; Togawa H; Tomonari T; Kato Y; Miura T; Mizuno M; Ichikawa T; Miyagi S; Shirasawa Y; Ito A; Yoshida A; Kimura G
    Clin Exp Nephrol; 2011 Oct; 15(5):708-713. PubMed ID: 21638004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ; Abid K; Ambreen F; Qureshi AL
    Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the rate of low-birth weight newborns and the incidence of end-stage renal disease in 47 prefectures in Japan.
    Imasawa T; Nakazato T
    Clin Exp Nephrol; 2012 Aug; 16(4):617-21. PubMed ID: 22358612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor.
    Costa-Scharplatz M; van Asselt AD; Bachmann LM; Kessels AG; Severens JL
    Pharmacogenet Genomics; 2007 May; 17(5):359-68. PubMed ID: 17429318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1.
    Perna A; Ruggenenti P; Testa A; Spoto B; Benini R; Misefari V; Remuzzi G; Zoccali C
    Kidney Int; 2000 Jan; 57(1):274-81. PubMed ID: 10620209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease.
    Sica DA; Gehr TW
    J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):247-54. PubMed ID: 12584668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the renin angiotensin system in dialysis patients.
    Cravedi P; Remuzzi G; Ruggenenti P
    Semin Dial; 2011; 24(3):290-7. PubMed ID: 21682771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.